Equities

Bellevue Life Sciences Acquisition Corp

BLAC:NAQ

Bellevue Life Sciences Acquisition Corp

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)11.62
  • Today's Change0.02 / 0.17%
  • Shares traded813.00
  • 1 Year change+11.30%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 17:02 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.

  • Revenue in USD (TTM)0.00
  • Net income in USD-474.86k
  • Incorporated2020
  • Employees--
  • Location
    Bellevue Life Sciences Acquisition Corp10900 Ne 4Th Street, Suite 2300BELLEVUE 98004United StatesUSA
  • Phone+1 (425) 635-7700
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Trilinc Global Impact Fund LLC15.59m11.61m44.34m--4.730.1971--2.840.24290.24290.32645.830.0551--0.7828--4.10-0.14224.19-0.145821.7651.7474.43-1.51----0.00---41.97-18.87101.24-52.27----
Yotta Acquisition Corp0.00518.38k44.38m2.0085.29------0.13190.13190.00-0.73410.00----0.002.07--20.29----------------------884.52------
Integral Acquisition Corp 10.0011.68k44.44m----4.60-----0.0255-0.02550.002.370.00------0.0492--0.0582--------------0.1897------205.91------
DUET Acquisition Corp0.004.40m44.44m--20.317.02----0.55870.55870.001.620.00------1.53--1.74--------------0.297------1,006.08------
Four Leaf Acquisition Corp0.00721.72k45.27m3.00112.461.84346.61--0.09870.09870.006.020.00----0.001.67--1.75--------------0.0532------13,329.64------
Binah Capital Group Inc166.23m-3.68m45.32m130.00--16.72--0.2727-0.2224-0.222410.041.042.50--15.941,278,683.00-4.43---7.17--17.26---1.77----0.25820.5926---6.09---37.28------
Inception Growth Acquisition Ltd0.00133.62k45.57m--293.105.15341.05--0.03990.03990.002.270.00------0.4266--0.6542--------------0.144------34.62------
Kairous Acquisition Corp Ltd0.00107.19k45.90m--435.514.46657.14--0.02860.02860.002.790.00------0.5477--0.6206--------------0.22-------76.26------
Bannix Acquisition Corp0.00-241.01k45.92m-----------0.0656-0.06560.00-0.47890.00-------1.34---1.77-----------------------220.65------
Nuveen New Yrk Slct Tx Fr ncm Prtfl2.19m3.15m46.35m--14.730.9254--21.150.8020.8020.558312.760.0441--3.42--6.33--6.36--93.40--143.65------0.00--9.29--176.65------
Breeze Holdings Acquisition Corp0.00-5.30m46.39m-----------1.16-1.160.00-1.250.00-------44.70---156.91-----------------------167.29------
Bellevue Life Sciences Acquisition Corp0.00-474.86k46.88m----3.14-----0.0992-0.09920.003.690.00-------1.02---1.08--------------0.1065------1,240.94------
Arogo Capital Acquisition Corp0.00-612.58k48.07m3.00--4.75-----0.0221-0.02210.002.330.00-------1.66---1.84--------------0.1376------301.27------
Marygold Companies Inc32.51m-5.16m48.39m116.00--1.90--1.49-0.1272-0.12720.80260.63310.91154.0319.36280,275.90-14.453.82-17.614.4672.8975.35-15.863.412.90--0.1269---5.854.03-449.26--1.48--
Alpha Star Acquisition Corp0.002.53m49.25m--52.296.6019.48--0.22930.22930.001.820.00------4.58--4.84--------------0.0047------344.76------
Mars Acquisition Corp0.001.75m49.43m--59.991.19----0.18420.18420.009.290.00------3.68--3.72--------------0.02------62,094.12------
Data as of Nov 21 2024. Currency figures normalised to Bellevue Life Sciences Acquisition Corp's reporting currency: US Dollar USD

Institutional shareholders

38.52%Per cent of shares held by top holders
HolderShares% Held
Wolverine Asset Management LLCas of 30 Sep 2024267.07k6.61%
Walleye Capital LLCas of 30 Sep 2024262.70k6.50%
RiverNorth Capital Management LLCas of 30 Sep 2024245.12k6.07%
TD Securities (USA) LLCas of 30 Sep 2024185.76k4.60%
W.R. Berkley Corp. (Investment Portfolio)as of 30 Sep 2024173.90k4.30%
Clear Street LLCas of 30 Sep 2024130.68k3.23%
AQR Arbitrage LLCas of 30 Sep 2024125.00k3.09%
Warberg Asset Management LLCas of 30 Sep 202480.23k1.99%
The Quarry LPas of 30 Sep 202465.00k1.61%
G1 Execution Services LLCas of 30 Sep 202421.01k0.52%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.